ViroPharma (NASDAQ: VPHM) is higher Wednesday following positive Germany-initial reimbursement on Plenadren.

"We believe Plenadren, a new formulation of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE